Evidence method
Level · gp.fundamentals.debt_to_revenue
350.11% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HAE · Jun 27, 2026
HAEMONETICS CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000313143-26-000120General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.33% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.42% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
5.60% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
90.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
59.76% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
16.93% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.77% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.74% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 30, 20240/8 normalizedLevel 3Jun 29, 20240/8 normalizedLevel 3Sep 28, 20240/8 normalizedLevel 3Dec 28, 20240/8 normalizedLevel 3Mar 29, 20250/9 normalizedLevel 3Jun 28, 20250/9 normalizedLevel 3Sep 27, 20250/9 normalizedLevel 3Dec 27, 20250/9 normalizedLevel 3Mar 28, 20268/9 normalizedLevel 3Jun 27, 20268/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 92.94%
- Current
- 350.11%
- Delta
- 257.17%
- Previous
- 2.46%
- Current
- 2.33%
- Delta
- -0.13%
- Previous
- 21.98%
- Current
- 15.42%
- Delta
- -6.56%
- Previous
- -1.97%
- Current
- 5.60%
- Delta
- 7.57%
- Previous
- 22.97%
- Current
- 90.38%
- Delta
- 67.42%
- Previous
- 59.04%
- Current
- 59.76%
- Delta
- 0.72%
- Previous
- 11.75%
- Current
- 16.93%
- Delta
- 5.18%
- Previous
- 4.48%
- Current
- 4.77%
- Delta
- 0.29%
- Previous
- 2.54%
- Current
- 2.74%
- Delta
- 0.21%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Surgical & Medical Instruments & Apparatus peers →Has State · HAEMONETICS CORP →Transitioned To · HAE Fundamental State →Transitioned To · HAE BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · HAE CAPEX_INTENSITY_DECREASED →Transitioned To · HAE CASH_GENERATION_DECREASED →Transitioned To · HAE GROWTH_INCREASED →Transitioned To · HAE INVENTORY_PRESSURE_INCREASED →Transitioned To · HAE MARGIN_INCREASED →Transitioned To · HAE PROFITABILITY_INCREASED →Transitioned To · HAE R_AND_D_INTENSITY_INCREASED →Transitioned To · HAE SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.